Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00195728 · ClinicalTrials.gov registry record · Phase 3

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

A Phase 3 study, sponsored by Abbott.

Completed
Registry status
Phase 3
Development phase
431
Enrollment target

NCT00195728 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 431 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00195728, a Phase 3 study, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 3
Development phase
431 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the safety of Vicodin CR (combination opioid and acetaminophen containing product) in patients with chronic pain due to osteoarthritis or low back pain.

Interventions

  • DRUG Hydrocodone/Acetaminophen on Extended Release

Trial Details

FieldValue
Enrollment Target 431 participants
Start Date 2005-06
Est. Completion 2006-12
Phase Phase 3

Sponsor

Abbott

181 total trials

What the Registry Record Tells You About NCT00195728

The ClinicalTrials.gov registry entry for NCT00195728 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 431 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hydrocodone/Acetaminophen on Extended Release is the first listed.

NCT00195728 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00195728 about?

NCT00195728 is a clinical study titled "Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain". The purpose of the study is to evaluate the safety of Vicodin CR (combination opioid and acetaminophen containing product) in patients with chronic pain due to osteoarthritis or low back pain.

What is the current status of trial NCT00195728?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 431 participants. The study started on 2005-06. Estimated completion is 2006-12.

What interventions are being tested in trial NCT00195728?

The interventions under investigation include: Hydrocodone/Acetaminophen on Extended Release (DRUG).

Who is sponsoring clinical trial NCT00195728?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.